Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Esther G C, Troost"'
Autor:
Iram Shahzadi, Annekatrin Seidlitz, Bettina Beuthien-Baumann, Alex Zwanenburg, Ivan Platzek, Jörg Kotzerke, Michael Baumann, Mechthild Krause, Esther G. C. Troost, Steffen Löck
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Personalized treatment strategies based on non-invasive biomarkers have potential to improve patient management in patients with newly diagnosed glioblastoma (GBM). The residual tumour burden after surgery in GBM patients is a prognostic ima
Externí odkaz:
https://doaj.org/article/0cb44df618b04c51a1088cc64d371f11
Autor:
Sergej Schneider, Sarah Stefanowicz, Christina Jentsch, Fabian Lohaus, Julia Thiele, Danilo Haak, Chiara Valentini, Ivan Platzek, Esther G. C. Troost, Aswin L. Hoffmann
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 38, Iss , Pp 111-116 (2023)
Background and purpose: Motion mitigation is of crucial importance in particle therapy (PT) of patients with abdominal tumors to ensure high-precision irradiation. Magnetic resonance imaging (MRI) is an excellent modality for target volume delineatio
Externí odkaz:
https://doaj.org/article/29433faaa98a48de87e370cf0adcf722
Autor:
Asier Rabasco Meneghetti, Alex Zwanenburg, Annett Linge, Fabian Lohaus, Marianne Grosser, Gustavo B. Baretton, Goda Kalinauskaite, Ingeborg Tinhofer, Maja Guberina, Martin Stuschke, Panagiotis Balermpas, Jens von der Grün, Ute Ganswindt, Claus Belka, Jan C. Peeken, Stephanie E. Combs, Simon Böke, Daniel Zips, Esther G. C. Troost, Mechthild Krause, Michael Baumann, Steffen Löck
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) may benefit from personalised treatment, requiring biomarkers that characterize the tumour and predict treatment response. We integrate pre-treatment CT radiomics a
Externí odkaz:
https://doaj.org/article/c1dcd98b39744271b0c678eabb5a6b58
Autor:
Filippo Lococo, Luca Boldrini, Charles-Davies Diepriye, Jessica Evangelista, Camilla Nero, Sara Flamini, Angelo Minucci, Elisa De Paolis, Emanuele Vita, Alfredo Cesario, Salvatore Annunziata, Maria Lucia Calcagni, Marco Chiappetta, Alessandra Cancellieri, Anna Rita Larici, Giuseppe Cicchetti, Esther G. C. Troost, Róza Ádány, Núria Farré, Ece Öztürk, Dominique Van Doorne, Fausto Leoncini, Andrea Urbani, Rocco Trisolini, Emilio Bria, Alessandro Giordano, Guido Rindi, Evis Sala, Giampaolo Tortora, Vincenzo Valentini, Stefania Boccia, Stefano Margaritora, Giovanni Scambia
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/7e9643c29ccd4c078536194810ca331d
Autor:
Iram Shahzadi, Alex Zwanenburg, Annika Lattermann, Annett Linge, Christian Baldus, Jan C. Peeken, Stephanie E. Combs, Markus Diefenhardt, Claus Rödel, Simon Kirste, Anca-Ligia Grosu, Michael Baumann, Mechthild Krause, Esther G. C. Troost, Steffen Löck
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Radiomics analyses commonly apply imaging features of different complexity for the prediction of the endpoint of interest. However, the prognostic value of each feature class is generally unclear. Furthermore, many radiomics models lack inde
Externí odkaz:
https://doaj.org/article/e1c65883dec344c2935384d3259061ee
Autor:
Sebastian Zschaeck, Julian Weingärtner, Elia Lombardo, Sebastian Marschner, Marina Hajiyianni, Marcus Beck, Daniel Zips, Yimin Li, Qin Lin, Holger Amthauer, Esther G. C. Troost, Jörg van den Hoff, Volker Budach, Jörg Kotzerke, Konstantinos Ferentinos, Efstratios Karagiannis, David Kaul, Vincent Gregoire, Adrien Holzgreve, Nathalie L. Albert, Pavel Nikulin, Michael Bachmann, Klaus Kopka, Mechthild Krause, Michael Baumann, Joanna Kazmierska, Paulina Cegla, Witold Cholewinski, Iosif Strouthos, Klaus Zöphel, Ewa Majchrzak, Guillaume Landry, Claus Belka, Carmen Stromberger, Frank Hofheinz
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Purpose18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is utilized for staging and treatment planning of head and neck squamous cell carcinomas (HNSCC). Some older publications on the prognostic relevance showed inconclusive results, mo
Externí odkaz:
https://doaj.org/article/2f07b591baee437aa851d7fe7869f85d
Autor:
Relinde I. Y. Lieverse, Evert J. Van Limbergen, Cary J. G. Oberije, Esther G. C. Troost, Sine R. Hadrup, Anne-Marie C. Dingemans, Lizza E. L. Hendriks, Franziska Eckert, Crispin Hiley, Christophe Dooms, Yolande Lievens, Monique C. de Jong, Johan Bussink, Xavier Geets, Vincenzo Valentini, Giuliano Elia, Dario Neri, Charlotte Billiet, Amir Abdollahi, David Pasquier, Pierre Boisselier, Ala Yaromina, Dirk De Ruysscher, Ludwig J. Dubois, Philippe Lambin
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background About 50% of non-small cell lung cancer (NSCLC) patients have metastatic disease at initial diagnosis, which limits their treatment options and, consequently, the 5-year survival rate (15%). Immune checkpoint inhibitors (ICI), eit
Externí odkaz:
https://doaj.org/article/3d19c81b16c745a58482aa1902edf103
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-11 (2018)
Abstract Background Neoadjuvant radio(chemo)therapy of non-metastasized, borderline resectable or unresectable locally advanced pancreatic cancer is complex and prone to cause side-effects, e.g., in gastrointestinal organs. Intensity-modulated proton
Externí odkaz:
https://doaj.org/article/bd414d4d7afd4115a21fa0d332ea1e20
Autor:
Macarena Cubillos-Mesías, Michael Baumann, Esther G. C. Troost, Fabian Lohaus, Steffen Löck, Christian Richter, Kristin Stützer
Publikováno v:
Radiation Oncology, Vol 12, Iss 1, Pp 1-10 (2017)
Abstract Background Proton beam therapy is promising for the treatment of head and neck cancer (HNC), but it is sensitive to uncertainties in patient positioning and particle range. Studies have shown that the planning target volume (PTV) concept may
Externí odkaz:
https://doaj.org/article/625506f171f3460d99670913a202de52
Autor:
Felix Wagner, Ulrike Hölig, Friederike Wilczkowski, Ioana Plesca, Ulrich Sommer, Rebekka Wehner, Maximilian Kießler, Armin Jarosch, Katharina Flecke, Maia Arsova, Antje Tunger, Andreas Bogner, Christoph Reißfelder, Jürgen Weitz, Knut Schäkel, Esther G. C. Troost, Mechthild Krause, Gunnar Folprecht, Martin Bornhäuser, Michael P. Bachmann, Daniela Aust, Gustavo Baretton, Marc Schmitz
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Neoadjuvant radiochemotherapy (nRCT) can significantly influence the tumor immune architecture that plays a pivotal role in regulating tumor growth. Whereas, various studies have investigated the effect of nRCT on tumor-infiltrating T cells, little i
Externí odkaz:
https://doaj.org/article/030ea4ff884e4213904d09e1d8759f7a